Andrew Blauvelt

72PUBLICATIONS
151CO-AUTHORS
Radiation therapyFluid-structure interaction and aeroacousticsPharmacogenomicsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|Jul 13, 2026
Post Hoc Subgroup and Body Region Analyses of VASI Outcomes Among Patients with Vitiligo in a Phase 2 Povorcitinib Trial.

|Jun 11, 2026
Roflumilast foam versus vehicle foam for seborrheic dermatitis (STRATUM clinical study): a plain language summary.

|Jun 01, 2026
Benefit-risk profile comparison between dupilumab and upadacitinib: a structured benefit-risk assessment of the Heads Up trial.

|May 26, 2026
Real-World Evidence That As-Needed Dosing with Bimekizumab in Patients with Psoriasis Is Safe and Effective over Time.

|May 15, 2026
GRAPPA 2025 Collaborative Research Network Meeting: Difficult-to-Treat Psoriatic Arthritis and Future Strategies for Curing Psoriasis.

|Mar 07, 2026
Prolonged ruxolitinib cream treatment for vitiligo among patients with no or limited response in the first 6 months.

Albert Wolkerstorfer, Melinda J Gooderham, Michael Sebastian

Pageof 12

Frequent Collaborators

15 joint publications

Kim A Papp

14 joint publications

Kristian Reich

7 joint publications

Melinda J Gooderham

7 joint publications

April W Armstrong